News/ R&D/ Sales and Marketing Indivior’s once-monthly schizophrenia injection gets US green light Joy Persaud fda, FDA approval, Indivior, Perseris, schizophrenia 0 Comment Regulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia. Perseris (risperidone) won Share X Indivior’s once-monthly schizophrenia injection gets US green light https://pharmaphorum.com/news/indivior-schizophrenia-perseris-fda/